Korean Drug Co. Ltd (014570) — Strategic Asset Allocation Index
Korean Drug Co. Ltd (014570) has a Strategic Asset Allocation Index of 28.2% as of December 2024. Strategic assets (PP&E of ₩22.05 Billion plus long-term investments of ₩-) total ₩22.05 Billion, measured against net assets of ₩78.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Korean Drug Co. Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Korean Drug Co. Ltd Strategic Asset Allocation Index (2014–2024)
This chart shows how Korean Drug Co. Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2014 to 2024. As of December 2024, the index stands at 28.2%, representing strategic assets of ₩22.05 Billion against net assets of ₩78.11 Billion KRW. See 014570 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Korean Drug Co. Ltd (2014–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Korean Drug Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Korean Drug Co. Ltd (014570) market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 28.2% | ₩22.05 Billion | ₩22.05 Billion | ₩- | ₩78.11 Billion | ▼ -1.6 pp |
| 2023 | 29.8% | ₩23.00 Billion | ₩23.00 Billion | ₩- | ₩77.09 Billion | ▲ +7.9 pp |
| 2022 | 22.0% | ₩18.61 Billion | ₩18.61 Billion | ₩- | ₩84.71 Billion | ▲ +3.7 pp |
| 2021 | 18.3% | ₩14.00 Billion | ₩14.00 Billion | ₩- | ₩76.69 Billion | ▼ -1.2 pp |
| 2020 | 19.4% | ₩13.78 Billion | ₩13.78 Billion | ₩- | ₩70.87 Billion | ▼ -10.6 pp |
| 2019 | 30.1% | ₩19.56 Billion | ₩14.85 Billion | ₩4.71 Billion | ₩65.05 Billion | ▲ +2.1 pp |
| 2018 | 28.0% | ₩17.58 Billion | ₩12.63 Billion | ₩4.95 Billion | ₩62.80 Billion | ▲ +1.5 pp |
| 2017 | 26.5% | ₩15.11 Billion | ₩14.88 Billion | ₩229.04 Million | ₩56.97 Billion | ▼ -2.9 pp |
| 2016 | 29.4% | ₩15.78 Billion | ₩14.56 Billion | ₩1.22 Billion | ₩53.66 Billion | ▼ -2.1 pp |
| 2015 | 31.5% | ₩15.66 Billion | ₩14.92 Billion | ₩742.62 Million | ₩49.68 Billion | ▼ 0.0 pp |
| 2014 | 31.5% | ₩15.38 Billion | ₩15.22 Billion | ₩160.03 Million | ₩48.79 Billion | — |